3-Chloro-4-(3-Fluorobenzyloxy)aniline CAS 202197-26-0 Lapatinib Intermedia Puritas >98.0% (HPLC)

Description:

Nomen chemicum: 3-Chloro-4-(3-Fluorobenzyloxy)aniline

CAS: 202197-26-0

Puritas: >98.0% (HPLC)

Aspectus: Brown ad nigrum pulverem

Ditosylate Monohydratorum

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica 3-Chloro-4-(3-Fluorobenzyloxy)anilineorum (CAS: 202197-26-0) magna qualitate.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Lapatinib Mediis,Please contact: alvin@ruifuchem.com

Lapatinib intermedia:

Lapatinib Base	CAS 231277-92-2
Lapatinib Ditosylate Monohydrate	CAS 388082-78-8
Sodium Methanesulfinate	CAS 20277-69-4
3-Chloro-4-(3-Fluorobenzyloxy)aniline	CAS 202197-26-0
2-Aminoethyl Methyl Sulfone Hydrochloridis	CAS 104458-24-4
4-Chloro-6-Iodoquinazoline	CAS 98556-31-1
6-Iodo-4-Hydroxyquinazoline	CAS 16064-08-7
5-Formyl-2-Acidi Furanboronic	CAS 27329-70-0
5-[4-[3-Chloro-4-(3-Fluorobenzyloxy)anilino]-6-Quinazolinyl]furan-2-Carboxaldehyde	CAS 231278-84-5

Chemical Properties:

Nomen chemicum	3-Chloro-4-(3-Fluorobenzyloxy)aniline
Synonyma	3-Chloro-4-[(3-Fluorophenyl)methoxy]anilineum;4-(3-Fluorobenzyloxy)-3-Chlorobenzenamine;Lapatinib medium B
Stock Status	In Stock, Commercial Productio
CAS Number	202197-26-0
Formulae hypotheticae	C13H11ClFNO
M. Pondus	251.69 g/mol
Liquescens punctum	78.0 ad 82.0℃
Density	1.306±0.06 g/cm3
COA & MSDS	Praesto
Sample	Praesto
Origin	Shanghai, China
Brand	Ruifu Chemical

Specifications:

Items	Signa inspectionis	Proventus
Aspectus	Brown ad nigrum pulveris	Obsequitur
Liquescens punctum	78.0 ad 82.0℃	80.7℃
Damnum in Siccatio	<1.00%	Obsequitur
Residere in Ignition	<0.50%	Obsequitur
Related immunditias ab HPLC	<2.00%	0.64%
Puritas / Analysis Methodus	>98.0% (HPLC)	99.36%
1H NMR Imaginum	Congruunt Structure	Obsequitur
conclusio	Productum probatum est et cum datis specificationibus obsequitur
Applicationem	Ditosylate Monohydratorum

Sarcina / at /naviportans:

Sarcina:Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in frigido, sicco et bene ventilato horreis a substantiis incompossibilibus repone.A luce et humore protege.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

202197-26-0 - Informationes Salutis:

UN IDs 3077
HS Codex 2921420090
Aleam Class IX
Stipare Group III

202197-26-0 - Applicatio:

3-Chloro-4-(3-Fluorobenzyloxy)anilineum (CAS: 202197-26-0) medium est in synthesi Lapatinib / Lapatinib Ditosylate Monohydratorum.
Lapatinib medicamentum est cancer pectoris impressi a GlaxoSmithKline Co. Humani ErbB receptores humani receptatores generis I tyrosini kinasi (TK) receptoris familiae, incluso ErbB1 (EGFR), ErbB2 (HER2), ErbB3 (HER3), et ErbB4 (HER4) .Receptores ErbB-I (EGFR) et ErbB-2 (ER-2) receptores saepe expressi vel aliter in aegros cancer mutati sunt.Humanum auctum epidermalis factor receptoris 2 (ErbB-2, HER-2) notum est hominem esse oncogene cum cancro pectori propinqua.Altitudo eius expressio in cancro pectori saepe metastasim nodi lymphatici praedicat et differentiam tumoris pauperis, cum prognosi paupere.HER-2 una e scoporum moleculis pro justo carcinomate specialium.eodem tempore agere potest Lapatinib Her-utraquc 1 Her-2.Effectus biologici huius methodi inhibentes prolificationem et incrementum cellularum tuberculorum multo maiores sunt quam solum unum scopum agentes.Compositum Lapatinib cum Capecitabine aegros cum carcinomate metastatico provecto vel carcinomate praecedente tractare cum receptore 2 epidermali humano, cum anthracyclinis, paclitaxel et trastuzumab iam tractatis.Cuscicae probationes ostenderunt Lapatinib etiam efficacius HER2-type aegros cum resistentia cancri Herceptini tractare.